Grace Hsu

Director, Real-World Evidence

Grace is Director of Real-World Evidence at Cytel providing statistical consulting and guiding project strategy for the application of advanced analytics to clinical and RWE generation. She also develops statistical communications and training for non-statisticians. Examples of her peer-reviewed publications include work on COVID-19, synthetic/external control arm comparative effectiveness analysis, quantitative bias analysis, Bayesian borrowing and other methods for comparative studies for both pharmaceutical research and HTA/regulatory submissions.

Grace holds a MSc in Statistics from SFU and BSc in Mathematics from UBC. Prior to joining Cytel, Grace was a senior statistician at MTEK Sciences (acquired by Cytel in 2019), a boutique analytics firm, where she worked with the Bill and Melinda Gates Foundation (BMGF), providing simulations and adaptive trial design for large-scale BMGF-funded clinical trials and analyzing national-level registries.